Outcomes for Anesthesiologist-Led Care of Analgesic Protocol in Anorectal Surgery
1 other identifier
interventional
216
1 country
2
Brief Summary
This will be an open, prospective, parallel-group, randomized controlled trial. Patients scheduled for complex anorectal surgery under general anesthesia will be enrolled, and the perioperative analgesia mode led by anesthesiologists will be established. Compared with the perioperative analgesia mode led by surgeons, the efficacy and safety of analgesia, quality of life and satisfaction of patients will be evaluated. This study is aimed at the feasibility and efficiacy of anesthesiologist-led treatment mode in the management of moderate and severe pain in patients after complex anorectal surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable postoperative-pain
Started Sep 2024
Typical duration for not_applicable postoperative-pain
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 17, 2023
CompletedFirst Posted
Study publicly available on registry
August 29, 2023
CompletedStudy Start
First participant enrolled
September 10, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 10, 2025
CompletedNovember 13, 2024
November 1, 2024
10 months
August 17, 2023
November 11, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
the time of recovery of work and life after surgery day
not requiring any additional medication and resuming full pre-operative work life content
up to 21 days
Secondary Outcomes (5)
postoperative rest pain
up to 21 days
postoperative defecation pain
up to 21 days
adverse reactions
up to 21 days
patients' satisfaction
up to 21 days
total opioid use after surgery
up to 21 days
Study Arms (2)
Anes Group
EXPERIMENTALIn Anes Group, the anesthesiologist routinely works in the operating room, and will communicate with anorectal physicians through bedside visits, video telephone calls, and a hospital-wide electronic medical record system in the operating room. Anesthesiologists will evaluate the patient's pain degree and symptoms perioperatively at bedside, and will administer opioids or non-opioids at the optimal interval and standard dose until discharge. The anesthesiologist and the surgeon will jointly formulate the discharge medication plan and give the patient guidance on analgesic treatment.
Surg. group
ACTIVE COMPARATORAccording to the current perioperative management mode, patients in the surgeon-led group (Surg. group) will be given local anesthesia during the operation, and will receive routine ambulatory surgery anesthesia plan, and routine postoperative analgesia plan in the ward will be given to the patients, under the guidance of the department of pharmacy. The patients will receive rescue opioids and standardized NSAIDs until discharge.
Interventions
For Anes. Group, hydromorphone intravenous pump (PCIA) with 0.04mg/hr and 0.2mg/hr bolus controlled administration. Rescue opioids will be given as sufentanil 5μg/hr, depending on the time of the last intraoperative administration. NSAIDs such as flurbiprofen axetil or ibuprofen will be administered as a complementary treatment option.
For Surg. Group, hydromorphone intravenous pump is set with the same analgesic formula as in Anes. Group. Routine prescriptions for rescue opioids (tramadol) and NSAIDs according to pain level recommended by the pharmacy department will be administered.
Multi-modal analgesia, including intraoperative long-acting local anesthetics (ropivacaine and methylene blue), perioperative narcotic analgesics, and postoperative laxative and antibiotics. PCIA with the same analgesic formula will be applied in both groups.
Eligibility Criteria
You may qualify if:
- American Society of Anesthesia (ASA) grading I-III
- ≥18 years old
- Patients scheduled for complex anorectal surgery under general anesthesia, e.g., mixed hemorrhoidectomy/sclerosing agent injection/ligation, radical anal fistula resection, peri-anal abscess incision and drainage
You may not qualify if:
- Informed consent not obtained
- Allergic to general anesthetics, hydromorphone, non-steroidal anti-inflammatory drugs and other related ingredients
- Opioid abuse or pathological pain that requires long-term analgesic treatment
- History of severe asthma attack and acute phase of asthma
- Moderate or above ventilatory function or diffusion dysfunction
- Liver dysfunction reached Child B grade; Renal insufficiency reached chronic kidney disease (CKD) stage IV
- Gastric retention and paralytic ileus
- Pregnant and lactating patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
China-Japan Friendship Hospital
Beijing, Beijing Municipality, 100029, China
Department of Anesthesiology
Beijing, Beijing Municipality, 100029, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Wei Xia Li, Doctor
China-Japan Friendship Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- This is an open label trial.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- attending doctor
Study Record Dates
First Submitted
August 17, 2023
First Posted
August 29, 2023
Study Start
September 10, 2024
Primary Completion
June 30, 2025
Study Completion
October 10, 2025
Last Updated
November 13, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share